Headlines from the Proactive UK newsroom.
Scancell (LON:SCLP) has received IND approval from the US FDA for its SCIB1 skin cancer treatment. the company will now start a US Phase 2 trial in combination with leading drug Keytruda to see if it reduces toxicity compared to other pairings.
Eco Atlantic (LON:ECO) has reported a 29% increase in the estimate for the amount of oil contained at its Orinduik Block, offshore Guyana. Gross prospective resources are now estimated at 5.14billion barrels on a best basis of which 771mln is net to Eco.
ADM Energy (LON:ADME) has signed a non-binding MOU with leading oil trading group Trafigura to look for opportunities in the African oil sector. ADM will act as the sponsor for opportunities to be presented to Trafigura either as a partner or where it can provide finance.
Chinese markets tumbled as they opened after the Lunar New Year holiday on fears of the impart of coronavirus. The Shanghai Composite index fell nearly 9% before rallying however healthcare shares soared.
Digital magazine publisher Future continues to power ahead. Strong organic revenue growth and higher margins means results this year will be materially ahead of current market expectations.